ABNB Airbnb | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.05 -6.9% | $145.00 ➝ $155.00 | Neutral ➝ Neutral | |
ABNB Airbnb | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.05 -6.9% | $160.00 | Neutral ➝ Neutral | |
ABNB Airbnb | Reiterated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.05 -6.9% | $145.00 ➝ $145.00 | Neutral ➝ Neutral | |
ABNB Airbnb | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.05 -6.9% | | Hold | |
ACAD ACADIA Pharmaceuticals | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.21 -11.2% | $37.00 | Overweight ➝ Overweight | |
ACAD ACADIA Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.21 -11.2% | $30.00 | Buy ➝ Buy | |
|
ACMR ACM Research | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.29 -1.1% | $34.00 | Buy ➝ Buy | |
ACVA ACV Auctions | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.47 +0.9% | $23.00 | Buy ➝ Buy | |
AFRM Affirm | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.81 +10.2% | | Hold | |
AG First Majestic Silver | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.49 +5.3% | $8.50 | Buy ➝ Buy | |
ALEC Alector | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.20 +0.2% | | Overweight | |
AMPH Amphastar Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.43 +0.5% | | Hold | |
ANIK Anika Therapeutics | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.26 -11.3% | $37.00 ➝ $37.00 | Outperform ➝ Outperform | |
APP AppLovin | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.69 +14.4% | | Hold | |
AQST Aquestive Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.29 +6.8% | $9.00 | Buy ➝ Buy | |
ARHS Arhaus | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.50 +17.2% | $17.00 ➝ $17.00 | Outperform ➝ Outperform | |
ARM ARM | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 103.59 -2.3% | | Hold | |
AVBP ArriVent BioPharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Burns Subscribe to MarketBeat All Access for the recommendation accuracy rating | $17.99 +3.6% | $25.00 | Buy ➝ Buy | |
BKSY BlackSky Technology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Buck Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.21 +3.4% | $2.50 | Buy ➝ Buy | |
CAKE Cheesecake Factory | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.06 +6.2% | $44.00 | Overweight | |
CART Maplebear | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.09 -3.7% | $45.00 ➝ $47.00 | Overweight ➝ Overweight | |
CDNA CareDx | Reiterated by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.06 +8.6% | $15.00 | Buy ➝ Buy | |
CDXC ChromaDex | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.52 -8.1% | $6.00 | Buy ➝ Buy | |
CRSP CRISPR Therapeutics | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.55 +0.5% | $86.00 | Market Outperform ➝ Market Outperform | |
CRSP CRISPR Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.55 +0.5% | | Neutral | |
CTMX CytomX Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.04 -51.3% | | Neutral | |
CXW CoreCivic | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.49 +0.8% | $19.00 | Outperform ➝ Outperform | |
CYTK Cytokinetics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.02 -1.9% | $108.00 | Buy ➝ Buy | |
DVAX Dynavax Technologies | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.01 -5.5% | $29.00 | Buy ➝ Buy | |
ENLT Enlight Renewable Energy | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.12 +0.2% | $19.00 ➝ $20.00 | Buy ➝ Buy | |
ERAS Erasca | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.96 -8.8% | $8.00 | Buy ➝ Buy | |
FEMY Femasys | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.27 -8.6% | $13.00 | Buy ➝ Buy | |
FNA Paragon 28 | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.25 -13.2% | $18.00 ➝ $15.00 | Overweight ➝ Overweight | |
FTEK Fuel Tech | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.31 +0.8% | $4.00 | Buy ➝ Buy | |
FVRR Fiverr International | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +10.2% | $33.00 | Buy ➝ Buy | |
GAIN Gladstone Investment | Reiterated by | LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.09 -0.5% | $14.00 ➝ $14.00 | Buy ➝ Neutral | |
GENI Genius Sports | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.45 +1.3% | $9.00 | Buy ➝ Buy | |
GILT Gilat Satellite Networks | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.57 -0.2% | $8.50 | Buy ➝ Buy | |
HL Hecla Mining | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.48 +11.6% | $10.25 | Buy ➝ Buy | |
HNST Honest | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.13 +6.1% | $4.00 ➝ $4.00 | Market Perform ➝ Market Perform | |
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
HUBS HubSpot | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $587.34 -0.5% | $730.00 | Buy ➝ Buy | |
HY Hyster-Yale Materials Handling | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $79.11 +8.5% | $85.00 ➝ $87.00 | Buy ➝ Buy | |
IFRX InflaRx | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.20
| $8.00 | Buy ➝ Buy | |
IGMS IGM Biosciences | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.12 +8.4% | $20.00 | Outperform ➝ Outperform | |
IMCR Immunocore | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.85 -2.4% | $81.00 | Buy ➝ Buy | |
IMXI International Money Express | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.12 +5.5% | $25.00 | Buy ➝ Buy | |
IONQ IonQ | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.20 +4.8% | $18.00 | Buy ➝ Buy | |
IPAR Inter Parfums | Reiterated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.59 +1.8% | $192.00 ➝ $192.00 | Buy ➝ Buy | |
JAMF Jamf | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.95 +1.2% | $25.00 | Buy ➝ Buy | |
JANX Janux Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.94 -6.2% | $100.00 | Overweight ➝ Overweight | |
KMDA Kamada | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.56 -3.1% | $11.00 | Buy ➝ Buy | |
KPTI Karyopharm Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.07 +4.9% | $8.00 | Buy ➝ Buy | |
KRNT Kornit Digital | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.57 +2.6% | $27.00 | Buy ➝ Buy | |
KROS Keros Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.60 -1.1% | $100.00 | Buy ➝ Buy | |
KVYO Klaviyo | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.97 +11.3% | $40.00 | Buy ➝ Buy | |
KVYO Klaviyo | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.97 +11.3% | $31.00 | Overweight ➝ Overweight | |
LEGN Legend Biotech | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.52 -0.4% | $87.00 | Buy ➝ Buy | |
LESL Leslie's | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.19 +10.7% | $6.00 ➝ $6.00 | Market Perform ➝ Market Perform | |
LPSN LivePerson | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.58 -7.9% | | Hold | |
LVLU Lulu's Fashion Lounge | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.78 +16.3% | $3.00 ➝ $3.00 | Market Perform ➝ Market Perform | |
MEG Montrose Environmental Group | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.05 -0.5% | $54.00 | Buy ➝ Buy | |
MGNI Magnite | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.23 +3.7% | $15.00 | Buy ➝ Buy | |
MIRM Mirum Pharmaceuticals | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.83 +3.2% | $40.00 | Overweight ➝ Overweight | |
MIRM Mirum Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.83 +3.2% | $58.00 | Buy ➝ Buy | |
MNKD MannKind | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.31 -2.0% | $6.50 | Overweight ➝ Overweight | |
MRUS Merus | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.12 -4.2% | $65.00 | Buy ➝ Buy | |
NABL N-able | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.93 +2.1% | $16.50 | Buy ➝ Buy | |
NI NiSource | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.90 +0.6% | $30.00 ➝ $31.00 | Outperform ➝ Outperform | |
NPCE NeuroPace | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Osborn Subscribe to MarketBeat All Access for the recommendation accuracy rating | $7.97 -36.7% | $18.00 | Overweight ➝ Overweight | |
NVEE NV5 Global | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $96.13 +2.3% | $121.00 ➝ $128.00 | Buy ➝ Buy | |
PCVX Vaxcyte | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $65.57 -1.8% | | Overweight | |
PCVX Vaxcyte | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.57 -1.8% | $95.00 | Buy ➝ Buy | |
PDSB PDS Biotechnology | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.83 -4.7% | | Overweight | |
PDSB PDS Biotechnology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.83 -4.7% | $21.00 | Buy ➝ Buy | |
PERI Perion Network | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.22 -3.4% | $18.00 | Buy ➝ Buy | |
PHAT Phathom Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.09 -0.1% | $26.00 | Buy ➝ Buy | |
PMT PennyMac Mortgage Investment Trust | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.72 +0.8% | $14.50 ➝ $15.00 | Neutral ➝ Neutral | |
PSNL Personalis | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.65 +5.1% | $3.50 | Buy ➝ Buy | |
PTGX Protagonist Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.27 +4.3% | $38.00 | Buy ➝ Buy | |
PWSC PowerSchool | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.12 -5.4% | $25.00 | Overweight | |
PYCR Paycor HCM | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.76 -15.7% | $42.00 | Buy ➝ Buy | |
PYPD PolyPid | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.50 +4.4% | $14.00 | Buy ➝ Buy | |
PZZA Papa John's International | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.22 -6.8% | $75.00 | Overweight ➝ Overweight | |
RCUS Arcus Biosciences | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.15 +5.8% | $30.00 | Outperform ➝ Outperform | |
RDWR Radware | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.72 +2.9% | | Hold | |
RITM Rithm Capital | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.31 +0.8% | $13.00 | Outperform ➝ Outperform | |
RMBL RumbleOn | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.17 +13.2% | $7.00 | Outperform ➝ Outperform | |
RNAC Cartesian Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $21.86 -6.0% | $54.00 | Buy ➝ Buy | |
RNG RingCentral | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.46 +3.1% | $40.00 | Neutral ➝ Neutral | |
RVMD Revolution Medicines | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.45 -2.2% | $46.00 | Buy ➝ Buy | |
Gold Set to EXPLODE! (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
SANA Sana Biotechnology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating | $7.50 -21.0% | $12.00 | Buy ➝ Buy | |
SGHC Super Group | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.50
| $6.00 | Buy ➝ Buy | |
SHOP Shopify | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.47 -0.4% | | Hold | |
SNDX Syndax Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.97 -1.8% | $41.00 | Buy ➝ Buy | |
STE STERIS | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $226.04 +7.6% | $265.00 | Market Outperform ➝ Market Outperform | |
STNG Scorpio Tankers | Reiterated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.76 +1.8% | $90.00 ➝ $90.00 | Buy ➝ Buy | |
TFC Truist Financial | Reiterated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.10 +0.6% | $44.00 | In-Line | |
TNGX Tango Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.77 -1.8% | $17.00 | Buy ➝ Buy | |
TPR Tapestry | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.37 +3.6% | $54.00 ➝ $54.00 | Outperform ➝ Outperform | |
TTD Trade Desk | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.67 +3.1% | $105.00 ➝ $110.00 | Overweight ➝ Overweight | |
TTD Trade Desk | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.67 +3.1% | $100.00 | Buy ➝ Buy | |
TTD Trade Desk | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.67 +3.1% | $107.00 ➝ $108.00 | Outperform ➝ Outperform | |
USPH U.S. Physical Therapy | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.08 +1.1% | $122.00 ➝ $122.00 | Outperform ➝ Outperform | |
VERV Verve Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $6.36 +4.6% | $15.00 | Buy ➝ Buy | |
VLN Valens Semiconductor | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.49 +1.2% | $4.00 ➝ $4.00 | Buy ➝ Buy | |
VRDN Viridian Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.91 -6.6% | $30.00 | Buy ➝ Buy | |
WRBY Warby Parker | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.68 +18.0% | $19.00 ➝ $19.00 | Outperform ➝ Outperform | |
XPER Xperi | Reiterated by | BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.14 -6.6% | $30.00 ➝ $30.00 | Top Pick ➝ Top Pick | |
YOU Clear Secure | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.90 +4.2% | $34.00 ➝ $34.00 | Outperform ➝ Outperform | |
ZIMV ZimVie | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.97 +10.3% | | Hold | |